{"entity":{"type":"insider","cik":"0001297000","url":"/insider/0001297000","json_url":"/insider/0001297000.json","name":"Scots-Knight Denise","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":20,"n_filings":12,"first":"2005-11-16","last":"2024-09-16","span_basis":"filed_date"},"name_variants":[{"name":"Scots-Knight Denise","source":"filing","n_filings":2,"first_seen":"2024-06-27","last_seen":"2024-09-16"},{"name":"Pollard-Knight Denise","source":"filing","n_filings":10,"first_seen":"2005-11-16","last_seen":"2015-01-02"}],"transactions":[{"id":2550688,"accession":"0000950170-24-106976","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-106976","line_url":"/filing/0000950170-24-106976#line-2","is_derivative":false,"issuer_cik":"0001297000","issuer_name":"Mereo BioPharma Group plc","issuer_ticker":"MREO","issuer_name_source":null,"issuer_url":"/issuer/0001297000","owner_cik":"0001297000","owner_name":"Scots-Knight Denise","owner_display_name":"Scots-Knight Denise","owner_url":"/insider/0001297000","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60046.0,"shares_display":"60,046","price_per_share":4.221,"price_display":"4.22","price_state":"stated","total_value":253454.166,"total_display":"253,454.17","total_whole":"253,454","shares_owned_after":808921.0,"shares_owned_after_display":"808,921","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-13","filed_date":"2024-09-16","scope":"insider"},{"id":2550685,"accession":"0000950170-24-106976","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-106976","line_url":"/filing/0000950170-24-106976#line-1","is_derivative":false,"issuer_cik":"0001297000","issuer_name":"Mereo BioPharma Group plc","issuer_ticker":"MREO","issuer_name_source":null,"issuer_url":"/issuer/0001297000","owner_cik":"0001297000","owner_name":"Scots-Knight Denise","owner_display_name":"Scots-Knight Denise","owner_url":"/insider/0001297000","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28611.0,"shares_display":"28,611","price_per_share":4.4727,"price_display":"4.47","price_state":"stated","total_value":127968.4197,"total_display":"127,968.42","total_whole":"127,968","shares_owned_after":868967.0,"shares_owned_after_display":"868,967","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-12","filed_date":"2024-09-16","scope":"insider"},{"id":2417574,"accession":"0000950170-24-078465","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-078465","line_url":"/filing/0000950170-24-078465#line-2","is_derivative":false,"issuer_cik":"0001297000","issuer_name":"Mereo BioPharma Group plc","issuer_ticker":"MREO","issuer_name_source":null,"issuer_url":"/issuer/0001297000","owner_cik":"0001297000","owner_name":"Scots-Knight Denise","owner_display_name":"Scots-Knight Denise","owner_url":"/insider/0001297000","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":92273.0,"shares_display":"92,273","price_per_share":3.3932,"price_display":"3.39","price_state":"stated","total_value":313100.7436,"total_display":"313,100.74","total_whole":"313,101","shares_owned_after":709518.0,"shares_owned_after_display":"709,518","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-26","filed_date":"2024-06-27","scope":"insider"},{"id":2417570,"accession":"0000950170-24-078465","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-078465","line_url":"/filing/0000950170-24-078465#line-1","is_derivative":false,"issuer_cik":"0001297000","issuer_name":"Mereo BioPharma Group plc","issuer_ticker":"MREO","issuer_name_source":null,"issuer_url":"/issuer/0001297000","owner_cik":"0001297000","owner_name":"Scots-Knight Denise","owner_display_name":"Scots-Knight Denise","owner_url":"/insider/0001297000","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40712.0,"shares_display":"40,712","price_per_share":3.6939,"price_display":"3.69","price_state":"stated","total_value":150386.0568,"total_display":"150,386.06","total_whole":"150,386","shares_owned_after":801791.0,"shares_owned_after_display":"801,791","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-25","filed_date":"2024-06-27","scope":"insider"},{"id":8799852,"accession":"0001140361-15-000072","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-15-000072","line_url":"/filing/0001140361-15-000072#line-1","is_derivative":false,"issuer_cik":"0001297000","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001297000","owner_cik":"0001297000","owner_name":"Pollard-Knight Denise","owner_display_name":"Pollard-Knight Denise","owner_url":"/insider/0001297000","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3799.0,"shares_display":"3,799","price_per_share":21.6635,"price_display":"21.66","price_state":"stated","total_value":82299.6365,"total_display":"82,299.64","total_whole":"82,300","shares_owned_after":1943509.0,"shares_owned_after_display":"1,943,509","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-31","filed_date":"2015-01-02","scope":"insider"},{"id":6773097,"accession":"0001140361-14-046759","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-14-046759","line_url":"/filing/0001140361-14-046759#line-3","is_derivative":false,"issuer_cik":"0001297000","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001297000","owner_cik":"0001297000","owner_name":"Pollard-Knight Denise","owner_display_name":"Pollard-Knight Denise","owner_url":"/insider/0001297000","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5510.0,"shares_display":"5,510","price_per_share":21.649,"price_display":"21.65","price_state":"stated","total_value":119285.99,"total_display":"119,285.99","total_whole":"119,286","shares_owned_after":1947308.0,"shares_owned_after_display":"1,947,308","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-30","filed_date":"2014-12-30","scope":"insider"},{"id":6773093,"accession":"0001140361-14-046759","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-14-046759","line_url":"/filing/0001140361-14-046759#line-2","is_derivative":false,"issuer_cik":"0001297000","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001297000","owner_cik":"0001297000","owner_name":"Pollard-Knight Denise","owner_display_name":"Pollard-Knight Denise","owner_url":"/insider/0001297000","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9902.0,"shares_display":"9,902","price_per_share":21.6166,"price_display":"21.62","price_state":"stated","total_value":214047.5732,"total_display":"214,047.57","total_whole":"214,048","shares_owned_after":1952818.0,"shares_owned_after_display":"1,952,818","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-29","filed_date":"2014-12-30","scope":"insider"},{"id":6773089,"accession":"0001140361-14-046759","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-14-046759","line_url":"/filing/0001140361-14-046759#line-1","is_derivative":false,"issuer_cik":"0001297000","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001297000","owner_cik":"0001297000","owner_name":"Pollard-Knight Denise","owner_display_name":"Pollard-Knight Denise","owner_url":"/insider/0001297000","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2195.0,"shares_display":"2,195","price_per_share":21.6476,"price_display":"21.65","price_state":"stated","total_value":47516.482,"total_display":"47,516.48","total_whole":"47,516","shares_owned_after":1962720.0,"shares_owned_after_display":"1,962,720","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-26","filed_date":"2014-12-30","scope":"insider"},{"id":6487670,"accession":"0001140361-14-046335","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-14-046335","line_url":"/filing/0001140361-14-046335#line-1","is_derivative":false,"issuer_cik":"0001297000","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001297000","owner_cik":"0001297000","owner_name":"Pollard-Knight Denise","owner_display_name":"Pollard-Knight Denise","owner_url":"/insider/0001297000","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20654.0,"shares_display":"20,654","price_per_share":21.7057,"price_display":"21.71","price_state":"stated","total_value":448309.5278,"total_display":"448,309.53","total_whole":"448,310","shares_owned_after":1964915.0,"shares_owned_after_display":"1,964,915","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-19","filed_date":"2014-12-23","scope":"insider"},{"id":7074195,"accession":"0001140361-14-044800","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-14-044800","line_url":"/filing/0001140361-14-044800#line-3","is_derivative":false,"issuer_cik":"0001297000","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001297000","owner_cik":"0001297000","owner_name":"Pollard-Knight Denise","owner_display_name":"Pollard-Knight Denise","owner_url":"/insider/0001297000","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7940.0,"shares_display":"7,940","price_per_share":21.7744,"price_display":"21.77","price_state":"stated","total_value":172888.736,"total_display":"172,888.74","total_whole":"172,889","shares_owned_after":1985569.0,"shares_owned_after_display":"1,985,569","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-10","filed_date":"2014-12-10","scope":"insider"},{"id":7074193,"accession":"0001140361-14-044800","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-14-044800","line_url":"/filing/0001140361-14-044800#line-2","is_derivative":false,"issuer_cik":"0001297000","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001297000","owner_cik":"0001297000","owner_name":"Pollard-Knight Denise","owner_display_name":"Pollard-Knight Denise","owner_url":"/insider/0001297000","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23273.0,"shares_display":"23,273","price_per_share":21.7836,"price_display":"21.78","price_state":"stated","total_value":506969.7228,"total_display":"506,969.72","total_whole":"506,970","shares_owned_after":1993509.0,"shares_owned_after_display":"1,993,509","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-09","filed_date":"2014-12-10","scope":"insider"},{"id":7074190,"accession":"0001140361-14-044800","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-14-044800","line_url":"/filing/0001140361-14-044800#line-1","is_derivative":false,"issuer_cik":"0001297000","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001297000","owner_cik":"0001297000","owner_name":"Pollard-Knight Denise","owner_display_name":"Pollard-Knight Denise","owner_url":"/insider/0001297000","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1727.0,"shares_display":"1,727","price_per_share":21.6761,"price_display":"21.68","price_state":"stated","total_value":37434.6247,"total_display":"37,434.62","total_whole":"37,435","shares_owned_after":2016782.0,"shares_owned_after_display":"2,016,782","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-08","filed_date":"2014-12-10","scope":"insider"},{"id":6605959,"accession":"0001140361-14-044349","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-14-044349","line_url":"/filing/0001140361-14-044349","is_derivative":false,"issuer_cik":"0001297000","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001297000","owner_cik":"0001297000","owner_name":"Pollard-Knight Denise","owner_display_name":"Pollard-Knight Denise","owner_url":"/insider/0001297000","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":21.59803152,"price_display":"21.60","price_state":"stated","total_value":539950.788,"total_display":"539,950.79","total_whole":"539,951","shares_owned_after":2019264.0,"shares_owned_after_display":"2,019,264","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-05","filed_date":"2014-12-05","scope":"insider","n_lines":2},{"id":6403393,"accession":"0001140361-14-027378","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-14-027378","line_url":"/filing/0001140361-14-027378#line-1","is_derivative":false,"issuer_cik":"0001297000","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001297000","owner_cik":"0001297000","owner_name":"Pollard-Knight Denise","owner_display_name":"Pollard-Knight Denise","owner_url":"/insider/0001297000","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11485.0,"shares_display":"11,485","price_per_share":23.5889,"price_display":"23.59","price_state":"stated","total_value":270918.5165,"total_display":"270,918.52","total_whole":"270,919","shares_owned_after":2043509.0,"shares_owned_after_display":"2,043,509","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-06-30","filed_date":"2014-07-02","scope":"insider"},{"id":6669019,"accession":"0001140361-14-026846","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-14-026846","line_url":"/filing/0001140361-14-026846#line-1","is_derivative":false,"issuer_cik":"0001297000","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001297000","owner_cik":"0001297000","owner_name":"Pollard-Knight Denise","owner_display_name":"Pollard-Knight Denise","owner_url":"/insider/0001297000","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3252.0,"shares_display":"3,252","price_per_share":23.562,"price_display":"23.56","price_state":"stated","total_value":76623.624,"total_display":"76,623.62","total_whole":"76,624","shares_owned_after":2054994.0,"shares_owned_after_display":"2,054,994","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-06-25","filed_date":"2014-06-27","scope":"insider"},{"id":6529071,"accession":"0001140361-14-026658","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-14-026658","line_url":"/filing/0001140361-14-026658#line-2","is_derivative":false,"issuer_cik":"0001297000","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001297000","owner_cik":"0001297000","owner_name":"Pollard-Knight Denise","owner_display_name":"Pollard-Knight Denise","owner_url":"/insider/0001297000","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11764.0,"shares_display":"11,764","price_per_share":23.5736,"price_display":"23.57","price_state":"stated","total_value":277319.8304,"total_display":"277,319.83","total_whole":"277,320","shares_owned_after":2058246.0,"shares_owned_after_display":"2,058,246","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-06-24","filed_date":"2014-06-25","scope":"insider"},{"id":6529068,"accession":"0001140361-14-026658","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-14-026658","line_url":"/filing/0001140361-14-026658#line-1","is_derivative":false,"issuer_cik":"0001297000","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001297000","owner_cik":"0001297000","owner_name":"Pollard-Knight Denise","owner_display_name":"Pollard-Knight Denise","owner_url":"/insider/0001297000","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52797.0,"shares_display":"52,797","price_per_share":24.1951,"price_display":"24.20","price_state":"stated","total_value":1277428.6947,"total_display":"1,277,428.69","total_whole":"1,277,429","shares_owned_after":2070010.0,"shares_owned_after_display":"2,070,010","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-06-23","filed_date":"2014-06-25","scope":"insider"},{"id":4396056,"accession":"0001181431-13-041152","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-041152","line_url":"/filing/0001181431-13-041152#line-2","is_derivative":false,"issuer_cik":"0001297000","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001297000","owner_cik":"0001297000","owner_name":"Pollard-Knight Denise","owner_display_name":"Pollard-Knight Denise","owner_url":"/insider/0001297000","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":58824.0,"shares_display":"58,824","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":1000008.0,"total_display":"1,000,008.00","total_whole":"1,000,008","shares_owned_after":2122807.0,"shares_owned_after_display":"2,122,807","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-07-23","filed_date":"2013-07-23","scope":"insider"},{"id":1368467,"accession":"0000909518-05-000899","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000909518-05-000899","line_url":"/filing/0000909518-05-000899#line-1","is_derivative":false,"issuer_cik":"0001093649","issuer_name":"IDENIX PHARMACEUTICALS INC","issuer_ticker":"IDIX","issuer_name_source":null,"issuer_url":"/issuer/0001093649","owner_cik":"0001297000","owner_name":"Pollard-Knight Denise","owner_display_name":"Pollard-Knight Denise","owner_url":"/insider/0001297000","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":629498.0,"shares_display":"629,498","price_per_share":20.61,"price_display":"20.61","price_state":"stated","total_value":12973953.78,"total_display":"12,973,953.78","total_whole":"12,973,954","shares_owned_after":301476.0,"shares_owned_after_display":"301,476","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-11-14","filed_date":"2005-11-16","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":20,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":19,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":20},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001719714","name":"Mereo BioPharma Group plc","url":"/issuer/0001719714","role":"Director, Officer (Chief Executive Officer)","n_filings":2,"first_seen":"2024-06-27","last_seen":"2024-09-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001302573","name":"OncoMed Pharmaceuticals Inc","url":"/issuer/0001302573","role":"Director","n_filings":9,"first_seen":"2013-07-23","last_seen":"2015-01-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001093649","name":"IDENIX PHARMACEUTICALS INC","url":"/issuer/0001093649","role":"Director","n_filings":1,"first_seen":"2005-11-16","last_seen":"2005-11-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001297000","retrieved_at":"2026-08-25T23:21:32+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}